The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Warren Eric since 2022.
This trader's CIK number is 1916048.
At the time of last reporting, Warren Eric was the Chief Commercial Officer of Mineralys Therapeutics, Inc.. (stock ticker symbol MLYS).
Also see all insider trading activities at Mineralys Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ESPR | 0 | $0 | 2,903 | $4,445 | 0 | $0 |
| 2024 | ESPR | 0 | $0 | 5,657 | $11,893 | 0 | $0 |
| 2023 | ESPR | 0 | $0 | 7,644 | $29,495 | 0 | $0 |
| 2022 | ESPR | 1,000 | $7,460 | 1,444 | $9,204 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | MLYS | 0 | $0 | 104,124 | $2,696,290 | 104,124 | $1,378,601 |
1. Esperion Therapeutics, Inc. (ESPR)
2. Mineralys Therapeutics, Inc. (MLYS)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-04-17 | ESPR | Sale | 108 | .98 | 105 |
| 2025-03-18 | ESPR | Sale | 2,433 | 1.49 | 3,617 |
| 2025-02-19 | ESPR | Sale | 239 | 1.87 | 446 |
| 2025-01-17 | ESPR | Sale | 123 | 2.26 | 277 |
| 2024-12-17 | ESPR | Sale | 2,234 | 2.43 | 5,426 |
| 2024-11-19 | ESPR | Sale | 197 | 2.17 | 426 |
| 2024-10-17 | ESPR | Sale | 107 | 2.12 | 226 |
| 2024-09-17 | ESPR | Sale | 2,608 | 1.78 | 4,650 |
| 2024-08-19 | ESPR | Sale | 211 | 1.95 | 410 |
| 2024-07-17 | ESPR | Sale | 108 | 2.59 | 279 |
| 2024-05-17 | ESPR | Sale | 192 | 2.48 | 476 |
| 2023-09-20 | ESPR | Sale | 742 | 1.25 | 923 |
| 2023-08-18 | ESPR | Sale | 243 | 1.41 | 343 |
| 2023-07-19 | ESPR | Sale | 106 | 1.58 | 168 |
| 2023-06-21 | ESPR | Sale | 603 | 1.48 | 894 |
| 2023-05-17 | ESPR | Sale | 219 | 1.62 | 355 |
| 2023-04-19 | ESPR | Sale | 115 | 1.28 | 146 |
| 2023-03-17 | ESPR | Sale | 526 | 1.78 | 937 |
| 2023-03-07 | ESPR | Sale | 5,090 | 5.05 | 25,729 |
| 2022-10-18 | ESPR | Sale | 107 | 7.69 | 822 |
| 2022-09-19 | ESPR | Sale | 255 | 6.92 | 1,764 |
| 2022-08-31 | ESPR | Buy | 1,000 | 7.46 | 7,460 |
| 2022-08-17 | ESPR | Sale | 199 | 6.82 | 1,356 |
| 2022-07-19 | ESPR | Sale | 431 | 6.58 | 2,836 |
| 2022-06-17 | ESPR | Sale | 256 | 4.90 | 1,254 |
| 2022-05-17 | ESPR | Sale | 196 | 5.98 | 1,172 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-06-26 | MLYS | Option Ex | 104,124 | 13.24 | 1,378,601 |
| 2026-06-26 | MLYS | Sale | 104,124 | 25.89 | 2,696,290 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Warren Eric (Chief Commercial Officer of Mineralys Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.